2026年1月13日，厦门思泰克智能科技股份有限公司（以下简称"思泰克"）发布公告宣称，公司拟与公司实际控制人及董事长陈志忠先生共同对厦门纽立 特电子科技有限公司（以下简称"纽立特"）进行增资，总投资金额为人民币1700 万元。 其中，思泰克以自有资金出资人民币900万元，对应持有纽立特2.6201%的股权；陈志忠先生以自有资金出资人民币800万元，对应持有纽立特2.3290%的 股权。 截至本公告披露日，本次投资事项尚未签署正式协议。本次投资完成后，纽立特将成为公司的参股公司，不纳入公司合并报表范围，不会导致公司合并报 表范围变更。 纽立特成立于2021年，是一家专注于工业领域高功率超快激光器研发、生产、销售及售后技术服务的高新技术企业，掌握紫外飞秒激光器核心技术。其核 心产品包括高功率飞秒激光器、紫外/深紫外激光器和钛宝石激光器，产品广泛应用于OLED精密加工、消费电子、光伏、半导体检测及生物医疗等领域。 工业级飞秒激光器技术壁垒高，其凭借超短脉冲、高能量密度和精确聚焦能力，在多个领域展现出独特优势，应用领域广阔，可广泛应用于显示面板、半 导体、医疗和通信等领域。飞秒激光的"冷加工"特性使其在半导体前沿工 ...

来源：中国能源网 华鑫证券近日发布化工行业研究：丁二烯、丙烯腈等涨幅居前，硫磺、氟化铝等跌幅较大本周涨幅较大 的产品：丁二烯（上海石化，10.09%），丙烯腈（华东AN，7.29%），硝酸（安徽98%，6.67%），三 氯乙烯（华东地区，5.78%），甲醛（华东，4.46%），甲苯（华东地区，4.33%），顺丁橡胶（山东， 4.14%），二甲苯（东南亚FOB韩国，4.08%），盐酸（华东合成酸，2.99%），煤焦油（山西市场， 2.87%）。 以下为研究报告摘要： 投资要点 丁二烯、丙烯腈等涨幅居前，硫磺、氟化铝等跌幅较大本周涨幅较大的产品：丁二烯（上海石化， 10.09%），丙烯腈（华东AN，7.29%），硝酸（安徽98%，6.67%），三氯乙烯（华东地区， 5.78%），甲醛（华东，4.46%），甲苯（华东地区，4.33%），顺丁橡胶（山东，4.14%），二甲苯 （东南亚FOB韩国，4.08%），盐酸（华东合成酸，2.99%），煤焦油（山西市场，2.87%）。 本周跌幅较大的产品：苯酚（华东地区，-3.23%），磷酸一铵（金河粉状55%，-3.23%），VCM（CFR 东南亚，-3.39%），焦炭（山西市 ...

Group 1 - The core viewpoint of the report highlights significant price increases in certain chemical products such as butadiene and acrylonitrile, while others like sulfur and aluminum fluoride have seen substantial declines [1][2][4] - This week, the products with the largest price increases include butadiene (Shanghai Petrochemical, +10.09%), acrylonitrile (East China AN, +7.29%), and nitric acid (Anhui, +6.67%) [1][2] - Conversely, products with the largest price declines include liquid chlorine (East China, -21.55%), aluminum fluoride (Henan, -9.58%), and natural rubber (Malaysian No. 20 standard rubber SMR20, -4.68%) [2][4] Group 2 - The report suggests that the chemical industry is currently in a weak performance phase, with mixed results across different sub-sectors due to past capacity expansions and weak demand [4] - It emphasizes investment opportunities in glyphosate, fertilizers, and sectors benefiting from domestic demand and high dividend yields [4] - Specific recommendations include focusing on companies like Jiangshan Co. (600389) and Xingfa Group (600141) in the glyphosate sector, and China Heartland Fertilizer as a key recommendation [4]

证券日报网讯1月12日，道恩股份（002838）在互动平台回答投资者提问时表示，公司生产的HNBR产 品在航天航空、石油勘探、汽车等领域拥有广阔的应用前景，可实现进口替代。 ...

Core Viewpoint - The company, Slin Smart Drive, showcases its competitive advantages in import substitution through differentiated product manufacturing and a flexible production line that enhances responsiveness and efficiency in meeting customer demands [1][4]. Group 1: Import Substitution Competitiveness - The core competitive advantage lies in differentiated product manufacturing, supported by a tailored supply chain and supplier system [1][4]. - The company employs a "small batch, multiple varieties, quick response" flexible production line, which allows for adaptable production capacity, improved equipment utilization, and shortened production cycles while ensuring quality [1][4]. - As of September 30, 2025, the company achieved significant breakthroughs in product development, completing multiple high-value model R&D and mass production, setting a historical high in the number of new product models [1][4]. Group 2: Overseas Expansion - In 2024, the company's Thailand factory obtained the IATF16949 certification and the E-Ruling certification recognized by U.S. Customs [2][5]. - By 2025, the Thailand factory successfully passed ISO14001 and ISO45001 international certification audits, with ongoing third-phase investment construction and high capacity utilization through optimized production layout and supply chain collaboration [2][5]. - The company has established local service capabilities in the North American market, accelerating the pace of its global industrial layout [2][5]. Group 3: Robotics Component Production - The company is actively advancing the mass production of robotics components, including harmonic reducers, actuator modules, and specialized bearings, currently reaching small batch production [2][6]. - There is a synergy between the company's precision component manufacturing and robotics component production, allowing for shared R&D technologies and production equipment [2][6][7]. - The company is in active communication with domestic and international clients regarding robotics components, with progress reported as smooth, although no large-scale supply has been initiated yet [2][7].

投资者关系活动记录表 编号：2026-001 证券代码：301550 证券简称：斯菱智驱 浙江斯菱智能驱动集团股份有限公司 2、公司目前的海外布局如何？ 答：2024 年，斯菱泰国工厂已获得 IATF16949 体系 证书和美国海关认可的原产地证（E-Ruling 认证函）2025 年，斯菱泰国工厂成功通过了 ISO14001 环境管理体系 与 ISO45001 职业健康安全管理体系的国际认证审核， 泰国工厂第三期投资建设顺利推进，通过优化生产布局 和强化供应链协同，实现产能利用率持续高位运行。此 外，公司已建立北美市场的本地服务能力，将进一步加 快公司主业全球化产业布局的节奏。 投资者关系活动类别 ☑ 特定对象调研 □媒体采访 □新闻发布会 □现场参观 □分析师会议 □业绩说明会 □路演活动 □其他（请文字说明其他活动内容） 活动参与人员 景顺长城基金尹群勇、淡水泉基金刘耀阳、广发基金张 毅、大家资产李恩国、建信养老刘亚斌、长城基金吴驰、 农银汇理基金刘荫泽、农银汇理基金宋磊、惠升基金陆 浩然、易方达基金涂程亮、青俪投资袁翔、诺安基金杨 靖康 、博普资产刘世昌、巨子投资邱恩光、杰鼎基金李 华林、中安汇富基金 ...

Core Viewpoint - The A-share market has shown strength in early 2026, with significant gains in the semiconductor and non-ferrous sectors, while the previously quiet innovative drug sector has also regained attention, particularly in the Hong Kong market. The "brain-computer interface" trend is emerging, suggesting potential investment opportunities in the medical device sector [1][5]. Innovative Drug Sector Recovery - The innovative drug sector has seen a resurgence, with several ETFs, including the Jiashi China Securities Hong Kong Innovative Drug ETF and the Fuguo Hang Seng Hong Kong Innovative Drug and Healthcare ETF, rising over 7% within three days. Other related products have also shown gains of over 5% [3]. - After a period of decline in Q4 2025, many fund managers believe that current valuations in the innovative drug sector are attractive, indicating that 2026 may be a good time to invest in pharmaceuticals. The sector is expected to remain a key investment theme in 2026, with positive catalysts expected to drive stock prices [3][4]. Brain-Computer Interface Potential - The "brain-computer interface" concept has gained traction, with Elon Musk's Neuralink expected to begin mass production in 2026, signaling a potential commercialization milestone. This technology could significantly impact the medical device sector, offering solutions for patients with disabilities [6][7]. - The medical device sector is seen as a direct beneficiary of brain-computer interface advancements, with opportunities for innovation and market growth driven by supportive policies and domestic companies increasing their market share [6][7]. Focus on Overseas Expansion - Fund managers are emphasizing the importance of "overseas expansion" as a key factor in selecting companies. The innovative drug sector is expected to see significant differentiation, with a focus on companies that can effectively execute overseas collaborations and clinical trials [8][9]. - The two main pathways for Chinese pharmaceutical companies to expand internationally include the popular BD licensing model and the less common approach of establishing overseas channels. Companies with strong execution capabilities in these areas are likely to succeed in international markets [9].

站在潞安煤基清洁能源公司的观景平台上，视线所及是蓝天下铺展的"钢铁巨阵"：数十座银灰色塔器拔 地而起，周身缠满管道，银白与深灰的管线在钢结构框架间织成密网，顺着塔壁螺旋而上斜跨向邻座设 备，连缀起整片生产区。不远处，"坚定推进能源革命"的蓝底标语挂在塔群间隙里。 这一数字的背后，是一条特色鲜明的发展路径——从传统的煤炭洗选、焦化向煤制油、煤制气、煤制烯 烃等高端煤化工产品转型。而潞安180项目，正是当地煤化工产业链的核心引擎。 "我们首先将高硫煤通过气化炉进行气化处理，净化后的合成气在高温高压条件下，通过催化剂发生费 托合成反应，费托合成产生的液态烃类混合物经分馏、加氢等精制工艺，再转化为油。可以说，我们的 油是通过气转化而来，燃烧时比传统意义的石油更环保。"潞安煤基清洁能源公司首席师张国华向记者 介绍道。目前，该公司已开发出五大类54种产品、270个规格型号的煤基合成产品，从高密度航空煤油 到尼龙纤维，多个产品填补了国内空白，在高端化工市场占据了重要地位。 从"一块煤"，到"一滴油"，从"单一燃料"到"多元材料"，当地正把煤的价值"吃干榨净"，如今，这 滴"油"已经敲开了进口化替代的大门。 这里是潞安180 ...

Core Insights - The global analog integrated circuit (IC) industry is expected to continue its recovery trend into the first half of 2025, driven by the ongoing electrification and intelligent development of the manufacturing sector, as well as the emergence of new applications that increase demand for high-performance analog chips [1] Industry Overview - The external trade environment has faced significant fluctuations, posing challenges to the deeply globalized chip industry. Increased trade conflicts have raised performance volatility risks for the analog chip sector in mainland China. However, calls from domestic associations to reduce reliance on international chips may accelerate the import substitution process [1] Company Performance - The company is a leading provider of industrial-grade analog IC patterned wafers in China, focusing on research, development, and sales of analog IC products. It has a robust technology foundation in the analog IC field and offers a comprehensive design platform that integrates EDA and IP [1] - As of the first half of 2025, the company has over 850 product models, enabling applications across various sectors including industrial automation, IoT, automotive electronics, medical devices, and consumer electronics [1] - In the first half of 2025, the company achieved revenue of approximately RMB 291.7 million, a year-on-year increase of about 0.4%, with a gross margin of approximately 51.8% [2] Strategic Focus - The company continues to focus on the high-end industrial-grade analog IC patterned wafer market, adapting to industry demands and leveraging its core competencies in products, business, and technology to maintain its performance advantage [2] - The company is optimizing its semi-automated chip design methods based on machine learning and actively launching new industrial products, which effectively supports its customer-driven business expansion strategy [2] Profit Forecast - The company forecasts net profits attributable to shareholders of RMB 188 million, RMB 223 million, and RMB 265 million for the years 2025 to 2027, respectively. Based on a 30x PE ratio for 2026 and an exchange rate of HKD to RMB at 0.90, the target price is set at HKD 118.13, with an initial "buy" rating [2]

Core Viewpoint - The acquisition of 70% stake in Hengsuo Huawai by Huahai Chengke marks a significant step in enhancing the domestic semiconductor packaging materials industry, aiming to improve international competitiveness and technological capabilities in the sector [1][5]. Company Overview - Huahai Chengke, established in December 2010, is a national-level specialized and innovative "little giant" enterprise focused on the R&D and industrialization of semiconductor chip packaging materials, with a complete R&D and production system and independent intellectual property rights [1]. - Hengsuo Huawai is recognized as a national-level specialized and innovative "little giant" enterprise, with a strong global sales network and a product range that includes over a hundred models under the Hysol brand [2]. Financial Performance - As of December 31, 2024, Huahai Chengke reported total assets of 53.53 billion, total liabilities of 13.21 billion, and total equity of 40.33 billion, indicating growth from the previous year [4]. - The company's revenue for 2024 was 46.78 billion, with a net profit of 4.57 billion, reflecting an increase from 2023 [4]. Market Context - The semiconductor packaging materials market is projected to grow significantly, with epoxy molding compounds being critical for the semiconductor industry, as over 90% of semiconductor chips utilize these materials [4][5]. - The domestic demand for semiconductor supply chain security is urgent, given the low localization rate of high-performance packaging materials in China, which is only 10%-20% [4]. Acquisition Details - The acquisition of Hengsuo Huawai was valued at 1.12 billion, with payment structured through cash, shares, and convertible bonds, allowing for a balanced approach to meet various shareholder needs [6][7]. - The cash payment of 320 million was aimed at addressing short-term liquidity needs of certain shareholders, while share issuance and convertible bonds were designed to bind long-term value supporters [7][9][10]. Strategic Implications - The acquisition is expected to extend Huahai Chengke's production and sales base to international markets such as South Korea and Malaysia, enhancing its global market share and competitiveness [5]. - The multi-faceted payment structure of cash, shares, and convertible bonds is seen as a strategic move to mitigate risks associated with valuation discrepancies and to ensure a smooth integration post-acquisition [10][12]. Industry Outlook - The global semiconductor materials market is anticipated to grow by 3.8% in 2024, reaching approximately 67.5 billion, with packaging materials revenue expected to increase by 4.7% to 24.6 billion [5]. - The Chinese packaging materials market is projected to reach 7.86 billion by 2025, growing at a rate of 7.23% [5].